Rebecca Berhanu | Profiles RNS

Rebecca (Ribka) Berhanu, MD

Postdoctoral Fellow (previously held)

Boston University School of Public Health

Global Health

Websites

	LinkedIn
	ResearchGate
	Google Scholar

ORCID : 0000-0002-9692-8748

BU Research

Transmission of drug-resistant tuberculosis in a South African city with a high prevalence of HIV infection
08/04/2020 - 12/31/2021 (PI)
NIH/National Institute of Allergy & Infectious Diseases
5K08AI150352-02

Title

Yr	Title	Project-Sub Proj	Pubs

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

iCite Website Copy PMIDs To Clipboard

Burke RM, Sabet N, Ellis J, Rangaraj A, Lawrence DS, Jarvis JN, Falconer J, Tugume L, Bidwell G, Berhanu RH, MacPherson P, Ford N. Causes of hospitalisation among people living with HIV worldwide, 2014-23: a systematic review and meta-analysis. Lancet HIV. 2025 May; 12(5):e355-e366. PMID: 40157376

Vogt SL, Hlongwane K, Arora A, Otwombe K, Chetty D, Berhanu RH, Waja Z, Stevens W, Omar T, Martinson NA, Ambinder RF, Xian RR. Prolonged Diagnostic Interval Leads to High Lymphoma Related Mortality in a Prospective Cohort of People with HIV Undergoing Fine Needle Aspiration. Cancers (Basel). 2025 Mar 17; 17(6). PMID: 40149339; PMCID: PMC11941734; DOI: 10.3390/cancers17061005;

Delany-Moretlwe S, Hanscom B, Guo X, Nkabiito C, Mandima P, Nahirya PN, Mpendo J, Bhondai-Mhuri M, Mgodi N, Berhanu R, Farrior J, Piwowar-Manning E, Ford SL, Hendrix CW, Rinehart AR, Rooney JF, Adeyeye A, Landovitz RJ, Cohen MS, Hosseinipour MC, Marzinke MA. Evaluation of long-acting cabotegravir safety and pharmacokinetics in pregnant women in eastern and southern Africa: a secondary analysis of HPTN 084. J Int AIDS Soc. 2025 Jan; 28(1):e26401. PMID: 39748218; PMCID: PMC11695207; DOI: 10.1002/jia2.26401;

Boyles T, Berhanu RH, Gogela N, Gunter H, Lovelock T, Mphothulo N, Parker A, Rabie H, Richards L, Sinxadi P, Wattrus C, Moosa MY. Management of drug-induced liver injury in people with HIV treated for tuberculosis: 2024 update. South Afr J HIV Med. 2024; 25(1):1558. PMID: 38628909; PMCID: PMC11019071; DOI: 10.4102/sajhivmed.v25i1.1558;

Koethe JR, Eeds A, Stewart LV, Haas DW, Hildreth JEK, Mallal S, Wanjalla C, Perkins J, Ahonkhai A, Dong X, Berhanu R, Dash C. The Tennessee Center for AIDS Research HIV Research Training Program for Minority High School and Undergraduate Students: Development, Implementation, and Early Outcomes. J Acquir Immune Defic Syndr. 2023 Oct 01; 94(2S):S42-S46. PMID: 37707847; PMCID: PMC10503046; DOI: 10.1097/QAI.0000000000003261;

Martinson NA, Nonyane BAS, Genade LP, Berhanu RH, Naidoo P, Brey Z, Kinghorn A, Nyathi S, Young K, Hausler H, Connell L, Lutchminarain K, Swe Swe-Han K, Vreede H, Said M, von Knorring N, Moulton LH, Lebina L. Evaluating systematic targeted universal testing for tuberculosis in primary care clinics of South Africa: A cluster-randomized trial (The TUTT Trial). PLoS Med. 2023 May; 20(5):e1004237. PMID: 37216385; PMCID: PMC10263318; DOI: 10.1371/journal.pmed.1004237;

Berhanu RH, Lebina L, Nonyane BAS, Milovanovic M, Kinghorn A, Connell L, Nyathi S, Young K, Hausler H, Naidoo P, Brey Z, Shearer K, Genade L, Martinson NA. Yield of Facility-based Targeted Universal Testing for Tuberculosis With Xpert and Mycobacterial Culture in High-Risk Groups Attending Primary Care Facilities in South Africa. Clin Infect Dis. 2023 May 03; 76(9):1594-1603. PMID: 36610730; PMCID: PMC10156124; DOI: 10.1093/cid/ciac965;

Audet CM, Seabi T, Ngobeni S, Berhanu RH, Wagner RG. Pulmonary tuberculosis vs. Tindzhaka and Mafularha: A mixed methods inquiry of traditional healers' perceptions of tuberculosis in rural South Africa. PLOS Glob Public Health. 2023; 3(4):e0001611. PMID: 37083848; PMCID: PMC10121049; DOI: 10.1371/journal.pgph.0001611;

Berhanu RH, Jacobson KR. Tuberculosis Preventive Therapy for People With HIV Infection in High Tuberculosis Burden Settings: How Much Is Enough? Ann Intern Med. 2021 10; 174(10):1462-1463.View Related Profiles.

Jacobson, Karen
Berhanu, Rebecca

PMID: 34424729

Mokhele I, Jinga N, Berhanu R, Dlamini T, Long L, Evans D. Treatment and pregnancy outcomes of pregnant women exposed to second-line anti-tuberculosis drugs in South Africa. BMC Pregnancy Childbirth. 2021 Jun 28; 21(1):453.View Related Profiles.

Long, Lawrence
Berhanu, Rebecca

PMID: 34182944; PMCID: PMC8240388; DOI: 10.1186/s12884-021-03956-6;

Showing 10 of 45 results. Show More

Masuku SD, Berhanu R, Van Rensburg C, Ndjeka N, Rosen S, Long L, Evans D, Nichols BE. Managing multidrug-resistant tuberculosis in South Africa: a budget impact analysis. Int J Tuberc Lung Dis. 2020 04 01; 24(4):376-382.View Related Profiles.

Nichols, Brooke
Long, Lawrence
Berhanu, Rebecca
Rosen, Sydney

PMID: 32317060; PMCID: PMC7656447; DOI: 10.5588/ijtld.19.0409;

Jamieson L, Evans D, Berhanu R, Ismail N, Aucock S, Wallengren K, Long L. Data quality of drug-resistant tuberculosis and antiretroviral therapy electronic registers in South Africa. BMC Public Health. 2019 Dec 05; 19(1):1638.View Related Profiles.

Long, Lawrence
Berhanu, Rebecca

PMID: 31805982; PMCID: PMC6896407; DOI: 10.1186/s12889-019-7965-9;

Berry KM, Rodriguez CA, Berhanu RH, Ismail N, Mvusi L, Long L, Evans D. Treatment outcomes among children, adolescents, and adults on treatment for tuberculosis in two metropolitan municipalities in Gauteng Province, South Africa. BMC Public Health. 2019 Jul 22; 19(1):973.View Related Profiles.

Long, Lawrence
Berhanu, Rebecca

PMID: 31331311; PMCID: PMC6647101; DOI: 10.1186/s12889-019-7257-4;

van Rensburg C, Berhanu R, Hirasen K, Evans D, Rosen S, Long L. Cost outcome analysis of decentralized care for drug-resistant tuberculosis in Johannesburg, South Africa. PLoS One. 2019; 14(6):e0217820.View Related Profiles.

Long, Lawrence
Berhanu, Rebecca
Rosen, Sydney

PMID: 31170207; PMCID: PMC6553851; DOI: 10.1371/journal.pone.0217820;

Sineke T, Evans D, Schnippel K, van Aswegen H, Berhanu R, Musakwa N, Lönnmark E, Long L, Rosen S. The impact of adverse events on health-related quality of life among patients receiving treatment for drug-resistant tuberculosis in Johannesburg, South Africa. Health Qual Life Outcomes. 2019 May 31; 17(1):94.View Related Profiles.

Long, Lawrence
Berhanu, Rebecca
Rosen, Sydney

PMID: 31151398; PMCID: PMC6545023; DOI: 10.1186/s12955-019-1155-4;

Berhanu RH, Schnippel K, Kularatne R, Firnhaber C, Jacobson KR, Horsburgh CR, Lippincott CK. Discordant rifampicin susceptibility results are associated with Xpert® MTB/RIF probe B and probe binding delay. Int J Tuberc Lung Dis. 2019 03 01; 23(3):358-362.View Related Profiles.

Horsburgh, C.
Jacobson, Karen
Berhanu, Rebecca

PMID: 30940300; PMCID: PMC6495054; DOI: 10.5588/ijtld.16.0837;

Evans D, Sineke T, Schnippel K, Berhanu R, Govathson C, Black A, Long L, Rosen S. Impact of Xpert MTB/RIF and decentralized care on linkage to care and drug-resistant tuberculosis treatment outcomes in Johannesburg, South Africa. BMC Health Serv Res. 2018 Dec 17; 18(1):973.View Related Profiles.

Long, Lawrence
Berhanu, Rebecca
Rosen, Sydney

PMID: 30558670; PMCID: PMC6296148; DOI: 10.1186/s12913-018-3762-x;

Berhanu RH, David A, da Silva P, Shearer K, Sanne I, Stevens W, Scott L. Performance of Xpert MTB/RIF, Xpert Ultra, and Abbott RealTime MTB for Diagnosis of Pulmonary Tuberculosis in a High-HIV-Burden Setting. J Clin Microbiol. 2018 12; 56(12).View Related Profiles.

Sanne, Ian
Berhanu, Rebecca

PMID: 30305387; PMCID: PMC6258835; DOI: 10.1128/JCM.00560-18;

Hirasen K, Berhanu R, Evans D, Rosen S, Sanne I, Long L. High rates of death and loss to follow-up by 12 months of rifampicin resistant TB treatment in South Africa. PLoS One. 2018; 13(10):e0205463.View Related Profiles.

Sanne, Ian
Long, Lawrence
Berhanu, Rebecca
Rosen, Sydney

PMID: 30300403; PMCID: PMC6177165; DOI: 10.1371/journal.pone.0205463;

Berhanu RH, Schnippel K, Kularatne R, Firnhaber C, Jacobson KR, Horsburgh CR, Lippincott CK. Can patients afford the cost of treatment for multidrug-resistant tuberculosis in Ethiopia? Int J Tuberc Lung Dis. 2018 08 01; 22(8):358-362.View Related Profiles.

Horsburgh, C.
Jacobson, Karen
Berhanu, Rebecca

PMID: 29991400; PMCID: PMC6421943; DOI: 10.5588/ijtld.17.0837;

Evans D, Hirasen K, Berhanu R, Malete G, Ive P, Spencer D, Badal-Faesen S, Sanne IM, Fox MP. Predictors of switch to and early outcomes on third-line antiretroviral therapy at a large public-sector clinic in Johannesburg, South Africa. AIDS Res Ther. 2018 04 10; 15(1):10.View Related Profiles.

Sanne, Ian
Berhanu, Rebecca

PMID: 29636106; PMCID: PMC5891887; DOI: 10.1186/s12981-018-0196-9;

Schnippel K, Firnhaber C, Berhanu R, Page-Shipp L, Sinanovic E. Direct costs of managing adverse drug reactions during rifampicin-resistant tuberculosis treatment in South Africa. Int J Tuberc Lung Dis. 2018 04 01; 22(4):393-398. PMID: 29562986

Rohr JK, Ive P, Horsburgh CR, Berhanu R, Hoffmann CJ, Wood R, Boulle A, Giddy J, Prozesky H, Vinikoor M, Mwanza MW, Wandeler G, Davies MA, Fox MP. Brief Report: Assessing the Association Between Changing NRTIs When Initiating Second-Line ART and Treatment Outcomes. J Acquir Immune Defic Syndr. 2018 04 01; 77(4):413-416.View Related Profiles.

Horsburgh, C.
Fox, Matthew
Berhanu, Rebecca

PMID: 29206723; PMCID: PMC5825249; DOI: 10.1097/QAI.0000000000001611;

Evans D, Dahlberg S, Berhanu R, Sineke T, Govathson C, Jonker I, Lönnermark E, Fox MP. Social and behavioral factors associated with failing second-line ART - results from a cohort study at the Themba Lethu Clinic, Johannesburg, South Africa. AIDS Care. 2018 07; 30(7):863-870.View Related Profiles.

Fox, Matthew
Berhanu, Rebecca

PMID: 29463102; PMCID: PMC7317067; DOI: 10.1080/09540121.2017.1417527;

Schnippel K, Firnhaber C, Ndjeka N, Conradie F, Page-Shipp L, Berhanu R, Sinanovic E. Persistently high early mortality despite rapid diagnostics for drug-resistant tuberculosis cases in South Africa. Int J Tuberc Lung Dis. 2017 10 01; 21(10):1106-1111. PMID: 28911353

Nel JS, Lippincott CK, Berhanu R, Spencer DC, Sanne IM, Ive P. Does Disseminated Nontuberculous Mycobacterial Disease Cause False-Positive Determine TB-LAM Lateral Flow Assay Results? A Retrospective Review. Clin Infect Dis. 2017 10 01; 65(7):1226-1228.View Related Profiles.

Sanne, Ian
Berhanu, Rebecca

PMID: 28575238

Evans D, Schnippel K, Govathson C, Sineke T, Black A, Long L, Berhanu R, Rosen S. Treatment initiation among persons diagnosed with drug resistant tuberculosis in Johannesburg, South Africa. PLoS One. 2017; 12(7):e0181238.View Related Profiles.

Long, Lawrence
Berhanu, Rebecca
Rosen, Sydney

PMID: 28746344; PMCID: PMC5529007; DOI: 10.1371/journal.pone.0181238;

Schnippel K, Firnhaber C, Berhanu R, Page-Shipp L, Sinanovic E. Adverse drug reactions during drug-resistant TB treatment in high HIV prevalence settings: a systematic review and meta-analysis. J Antimicrob Chemother. 2017 07 01; 72(7):1871-1879. PMID: 28419314

Onoya D, Brennan AT, Berhanu R, van der Berg L, Buthelezi T, Fox MP. Changes in second-line regimen durability and continuity of care in relation to national ART guideline changes in South Africa. J Int AIDS Soc. 2016 Dec 21; 19(1):1-13.View Related Profiles.

Brennan, Alana
Fox, Matthew
Berhanu, Rebecca

PMID: 28364563; PMCID: PMC5463878; DOI: 10.7448/IAS.19.1.20675;

Shearer K, Evans D, Moyo F, Rohr JK, Berhanu R, Van Den Berg L, Long L, Sanne I, Fox MP. Treatment outcomes of over 1000 patients on second-line, protease inhibitor-based antiretroviral therapy from four public-sector HIV treatment facilities across Johannesburg, South Africa. Trop Med Int Health. 2017 Feb; 22(2):221-231.View Related Profiles.

Sanne, Ian
Long, Lawrence
Fox, Matthew
Berhanu, Rebecca

PMID: 27797443; PMCID: PMC5288291; DOI: 10.1111/tmi.12804;

Berhanu R, Schnippel K, Mohr E, Hirasen K, Evans D, Rosen S, Sanne I. Early Outcomes Of Decentralized Care for Rifampicin-Resistant Tuberculosis in Johannesburg, South Africa: An Observational Cohort Study. PLoS One. 2016; 11(11):e0164974.View Related Profiles.

Sanne, Ian
Berhanu, Rebecca
Rosen, Sydney

PMID: 27812140; PMCID: PMC5094796; DOI: 10.1371/journal.pone.0164974;

Evans D, Berhanu R, Moyo F, Nguweneza A, Long L, Fox MP. Can Short-Term Use of Electronic Patient Adherence Monitoring Devices Improve Adherence in Patients Failing Second-Line Antiretroviral Therapy? Evidence from a Pilot Study in Johannesburg, South Africa. AIDS Behav. 2016 Nov; 20(11):2717-2728.View Related Profiles.

Long, Lawrence
Fox, Matthew
Berhanu, Rebecca

PMID: 27146828; PMCID: PMC5069329; DOI: 10.1007/s10461-016-1417-7;

Schnippel K, Berhanu RH, Black A, Firnhaber C, Maitisa N, Evans D, Sinanovic E. Severe adverse events during second-line tuberculosis treatment in the context of high HIV Co-infection in South Africa: a retrospective cohort study. BMC Infect Dis. 2016 Oct 21; 16(1):593. PMID: 27769174; PMCID: PMC5073931; DOI: 10.1186/s12879-016-1933-0;

Rohr JK, Ive P, Horsburgh CR, Berhanu R, Shearer K, Maskew M, Long L, Sanne I, Bassett J, Ebrahim O, Fox MP. Developing a predictive risk model for first-line antiretroviral therapy failure in South Africa. J Int AIDS Soc. 2016; 19(1):20987.View Related Profiles.

Horsburgh, C.
Sanne, Ian
Long, Lawrence
Fox, Matthew
Berhanu, Rebecca

PMID: 27677395; PMCID: PMC5039239; DOI: 10.7448/IAS.19.1.20987;

Rohr JK, Ive P, Horsburgh CR, Berhanu R, Shearer K, Maskew M, Long L, Sanne I, Bassett J, Ebrahim O, Fox MP. Marginal Structural Models to Assess Delays in Second-Line HIV Treatment Initiation in South Africa. PLoS One. 2016; 11(8):e0161469.View Related Profiles.

Horsburgh, C.
Sanne, Ian
Long, Lawrence
Fox, Matthew
Berhanu, Rebecca

PMID: 27548695; PMCID: PMC4993510; DOI: 10.1371/journal.pone.0161469;

Gajee R, Schnippel K, Mthupha N, Muzah B, Berhanu R. Missed appointments among rifampicin-resistant tuberculosis (RR-TB) patients at a decentralised RR-TB outpatient clinic in Johannesburg, South Africa. S Afr Med J. 2016 Aug 07; 106(9):912-7. PMID: 27601119

Brennan AT, Bonawitz R, Schnippel K, Berhanu R, Maskew M, Long L, Bassett J, Sanne I, Fox MP. Incident tuberculosis in HIV-positive children, adolescents and adults on antiretroviral therapy in South Africa. Int J Tuberc Lung Dis. 2016 Aug; 20(8):1040-5.View Related Profiles.

Brennan, Alana
Sanne, Ian
Long, Lawrence
Fox, Matthew
Bonawitz, Rachael
Berhanu, Rebecca

PMID: 27393537; DOI: 10.5588/ijtld.15.0488;

Fox MP, Berhanu R, Steegen K, Firnhaber C, Ive P, Spencer D, Mashamaite S, Sheik S, Jonker I, Howell P, Long L, Evans D. Intensive adherence counselling for HIV-infected individuals failing second-line antiretroviral therapy in Johannesburg, South Africa. Trop Med Int Health. 2016 Sep; 21(9):1131-7.View Related Profiles.

Long, Lawrence
Fox, Matthew
Berhanu, Rebecca

PMID: 27383454; DOI: 10.1111/tmi.12741;

Schnippel K, Ndjeka N, Conradie F, Berhanu R, Claasen Z, Banoo S, Firnhaber C. A call to action: Addressing the reproductive health needs of women with drug-resistant tuberculosis. S Afr Med J. 2016 Mar 17; 106(4):30-1. PMID: 27032841

Schnippel K, Shearer K, Evans D, Berhanu R, Dlamini S, Ndjeka N. Predictors of mortality and treatment success during treatment for rifampicin-resistant tuberculosis within the South African National TB Programme, 2009 to 2011: a cohort analysis of the national case register. Int J Infect Dis. 2015 Oct; 39:89-94. PMID: 26358856

d'Elia A, Evans D, McNamara L, Berhanu R, Sanne I, Lönnermark E. Predictive and prognostic properties of TB-LAM among HIV-positive patients initiating ART in Johannesburg, South Africa. Pan Afr Med J. 2015; 22:4.View Related Profiles.

Sanne, Ian
Berhanu, Rebecca

PMID: 26600904; PMCID: PMC4643149; DOI: 10.11604/pamj.2015.22.4.6075;

Naidoo S, Evans D, Jong E, Mellet K, Berhanu R. Outcomes of TB/HIV co-infected patients presenting with antituberculosis drug-induced liver injury. S Afr Med J. 2015 Apr 07; 105(5):393-6. PMID: 26242667

Shearer K, Brennan AT, Maskew M, Long L, Berhanu R, Sanne I, Fox MP. The relation between efavirenz versus nevirapine and virologic failure in Johannesburg, South Africa. J Int AIDS Soc. 2014; 17:19065.View Related Profiles.

Brennan, Alana
Sanne, Ian
Long, Lawrence
Fox, Matthew
Berhanu, Rebecca

PMID: 25361827; PMCID: PMC4215701; DOI: 10.7448/IAS.17.1.19065;

Shearer K, Maskew M, Ajayi T, Berhanu R, Majuba P, Sanne I, Fox MP. Incidence and predictors of herpes zoster among antiretroviral therapy-naïve patients initiating HIV treatment in Johannesburg, South Africa. Int J Infect Dis. 2014 Jun; 23:56-62.View Related Profiles.

Sanne, Ian
Fox, Matthew
Berhanu, Rebecca

PMID: 24680820; PMCID: PMC4092228; DOI: 10.1016/j.ijid.2013.10.016;

Shearer K, Fox MP, Maskew M, Berhanu R, Long L, Sanne I. The impact of choice of NNRTI on short-term treatment outcomes among HIV-infected patients prescribed tenofovir and lamivudine in Johannesburg, South Africa. PLoS One. 2013; 8(8):e71719.View Related Profiles.

Sanne, Ian
Long, Lawrence
Fox, Matthew
Berhanu, Rebecca

PMID: 23940782; PMCID: PMC3737125; DOI: 10.1371/journal.pone.0071719;

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 45 publications over 12 distinct years, with a maximum of 11 publications in 2016

Bar chart showing 45 publications over 12 distinct years, with a maximum of 11 publications in 2016

Year	Publications
2013	1
2014	2
2015	3
2016	11
2017	4
2018	8
2019	5
2020	1
2021	2
2023	4
2024	1
2025	3

Contact for Mentoring:

801 Massachusetts Avenue
Boston MA 02118
Google Map

617.414.1260

Download vCard

Berhanu's Networks

Click the "See All" links for more information and interactive visualizations

Concepts

See all (145) concept(s)

Co-Authors

See all (8) people

Similar People

See all (60) people

Same Department

Search Department